Abstract
Interleukin-1β (IL-1β) is released during pathophysiological processes. IL-1β induces neurological manifestations when administered into the cerebrospinal fluid (CSF) at pathophysiological concentrations detected during central nervous system (CNS) infections and other neurological disorders. In the present study, we investigated the regulation of the IL-1β system in the CNS in response to the chronic intracerebroventricular (icv) microinfusion of IL-1β at estimated pathophysiological concentrations in the CSF. IL-1 receptor type I (IL-1RI), IL-1 receptor antagonist (IL-1Ra), and IL-1β mRNAs were determined by sensitive RNase protection assays in brain target regions for IL-1β (cerebellum, parieto-frontal cortex, hippocampus, and midbrain). The results show that chronic icv microinfusion of IL-1β induced significant anorexia, increased the cerebellar IL-1RI mRNA content, increased IL-1Ra and IL-1β mRNAs levels in the cerebellum > midbrain > cortex > hippocampus, and induced profiles of IL-1RI mRNA, IL-1Ra mRNA, and IL-1β mRNA that were highly intercorrelated. On the other hand, levels of rat glyceraldehyde 3-phosphate dehydrogenase mRNA and 18S rRNA were fairly constant, and heat-inactivated IL-1β had no effect on food intake or on IL-1RI, IL-1Ra, and IL-1β mRNAs levels in any brain region. The data suggest the operation of an IL-1β feedback system (IL-1β/IL-1Ra/IL-1RI) in brain regions. Dysregulation of the CNS IL-1β feedback system may have pathophysiological significance. This may be reflected, for example, in the pathogenicity and severity of neurological diseases, such as CNS infections.
Similar content being viewed by others
References
Akalin H., Akdis A. C., Mistik R., Helvaci S., and Kilicturgay K. (1994) Cerebrospinal fluid interleukin-1β/interleukin-1 receptor antagonist balance and tumor necrosis factor-α concentrations in tuberculous, viral and acute bacterial meningitis.Scand. J. Infect. Dis. 26, 667–674.
Arend W. P. (1991) Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.J. Clin. Invest. 88, 1445–1451.
Ban E., Sarlieve L., and Haour F. (1993) Interleukin-1 binding sites on astrocytes.Neuroscience 52, 725–733.
Baudrie V., Roullet J. B., Goureau Y., Chaouloff F., and Elghozi J. L. (1990) Determination of cerebrospinal fluid production rate using a push-pull perfusion procedure in the conscious rat.Fundam. Clin. Pharmacol. 4, 269–274.
Burtis C. A. and Ashwood E. R. (1994)Tietz Textbook of Clinical Chemistry, 2nd ed., Saunders, Philadelphia, PA.
Cacabelos R., Barquero M., Garcia P., Alvarez X. A., and Deseijas E. V. (1991) Cerebrospinal fluid interleukin-1β (IL-1β) in Alzheimer’s disease and neurological disorders.Meth. Find. Exp. Clin. Pharmacol. 13, 455–458.
Chomczynski P. (1993) A reagent for the single-step simultaneous isolation of RNA, DNA, and proteins from cell and tissue samples.Biotechniques 15, 532–537.
Cominelli F., Ferretti M., Nast C. C., Ng R., Eisenberg S. P., and Pizzarro T. T. (1993) Anti-interleukin-1 receptor antagonist treatment exacerbates and prolongs inflammation in rabbit immune colitis.Lymphokine Cytokine Res. 12, 340.
Cunningham E. T. Jr. and De Souza E. B. (1993) Interleukin 1 receptors in the brain and endocrine tissues.Immunol. Today 14, 171–176.
Cunningham E. T. Jr., Wada E., Carter D. B., Tracey D. E., Battey J. F., and De Souza E. B. (1992)In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse.J. Neurosci. 12, 1101–1114.
Dinarello C. A. (1994) The interleukin-1 family: 10 years of discovery.FASEB J. 8, 1314–1325.
Dower S. K., Bird T. A., and Sims J. E. (1992) Interleukin-1.Adv. Neuroimmunol. 2, 1–16.
Ericsson A., Liu C., Hart R. P., and Sawchenko P. E. (1995) Type 1 interleukin-1 receptor in the rat brain: distribution, regulation and relationship to sites of IL-1-induced cellular activation.J. Comp. Neurol. 361, 681–698.
Fan L., Young P. R., Barone F. C., Feuerstein G. Z., Smith D. H., and Mcintosh T. K. (1995) Experimental brain injury induces expression of interleukin-1β mRNA in the rat brain.Mol. Brain Res. 30, 125–130.
Farrar W. L., Kilian P. L., Ruff M. R., Hill J. M. and Pert C. B. (1987) Visualization and characterization of interleukin 1 receptors in brain.J. Immunol. 139, 459–463.
Freidin M., Bennett M. V. L., and Kessler J. A. (1992) Cultured sympathetic neurons synthesize and release the cytokine interleukin 1β.Proc. Natl. Acad. Sci. USA 89, 10,440–10,443.
Gabellec M. M., Griffais R., Fillion G., and Haour F. (1995) Expression of interleukin-1α, interleukin-1β and interleukin-1 receptor antagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment.Mol. Brain Res. 31, 122–130.
Giulian D. and Corpuz M. (1993) Microglial secretion products and their impact on the nervous system.Adv. Neurol. 59, 315–320.
Granowitz E. V., Vannier E., Poutsiaka D. D., and Dinarello C. A. (1992) Effect of interleukin-1 (IL-1) blockade on cytokine synthesis. II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes.Blood 79, 2364–2369.
Haour F., Marquette C., Ban E., Crumeyrolle-Arias M., Rostene W., Tsiang H., and Fillion G. (1995) Receptors for interleukin-1 in the central nervous and neuroendocrine systems.Annals d’Endocrinologie (Paris) 56, 173–179.
Hart R. P., Liu C., Shadiack A. M., McCormack R. J., and Miller Jonakait G. (1993) An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia.J. Neuroimmunol. 44, 49–56.
Hauser S. L., Doolittle T. H., Lincoln R., Brown R. H., and Dinarello C. A. (1990) Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.Neurology 40, 1735–1739.
Ilyin S. E., Sonti G., Molloy G., and Plata-Salamán C. R. (1996) Creatine kinase-B mRNA levels in brain regions from male and female rats.Mol. Brain Res., in press.
Jacobs R. F. and Tabor D. R. (1990) The immunology of sepsis and meningitis—cytokine biology.Scand. J. Infect. Dis. Suppl. 73, 7–15.
Jenkins J. K. and Arend W. P. (1993) Interleukin-1 receptor antagonist production in human monocytes is induced by IL-1α, IL-3, IL-4 and GM-CSF.Cytokine 5, 407–415.
Kuroda Y., Matsui M., Takashima H., and Kurohara K. (1993) Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy.J. Neuroimmunol. 45, 133–136.
Lai Y. L., Smith P. M., Lamm W. J. E., and Hildebrandt J. (1983) Sampling and analysis of cerebrospinal fluid for chronic studies in awake rats.J. Appl. Physiol. 54, 1754–1757.
Lechan R. M., Toni R., Clark B. D., Dannon J. G., Shaw A. R., Dinarello C. A., and Reichlin S. (1990) Immunoreactive interleukin-1β localisation in the rat forebrain.Brain Res. 514, 135–140.
Liu T., McDonnell P. C., Young P. R., White R. F., Siren A. L., Hallenbeck J. M., Barone F. C., and Feuerstein G. Z. (1993) INterleukin-1β mRNA expression in ischemic rat cortex.Stroke 24, 1746–1751.
López-Cortés L. F., Cruz-Ruiz N., Gómez-Mateos J., Jiménez-Hernández D., Palomino J., and Jiménez E. (1993) Measurement of levels of tumor necrosis factor-α and interleukin-1β in the CSF of patients with meningitis of different etiologies: utility in the differential diagnosis.Clin. Infect. Dis. 16, 534–539.
Maier W. E., Brown H. W., Tilson H. A., Luster M. I., and Harry G. J. (1995) Trimethyltin increases interleukin (IL)-1α, IL-6 and tumor necrosis factor α mRNA levels in rat hippocampus.J. Neuroimmunol. 59, 65–75.
Malinowsky D., Chai Z., Bristulf J., Simoncsits A., and Bartfai T. (1995) The type I interleukin-1 receptor mediates fever in the rat as shown by interleukin-1 receptor subtype selective ligands.Neurosci. Lett. 201, 33–36.
Mancilla J., Garcia P., and Dinarello C. A. (1993) IL-1 receptor antagonist can either protect or enhance the lethality ofKlebsiella pneumoniae sepsis in newborn rats.Infect. Immun. 61, 926–932.
Mann J. D., Butler A. B., Rosenthal J. E., Maffeo C. J., Johnson R. N., and Bass N. H. (1978) Regulation of intracranial pressure in rat, dog and man.Ann. Neurol. 3, 156–165.
Martel-Pelletier J., McCollum R., and Pelletier J.-P. (1993) The synthesis of IL-1 receptor antagonist (IL-1Ra) by synovial fibroblasts is markedly increased by the cytokines TNF-α and IL-1.Biochim. Biophys. Acta 1175, 302–305.
Mazzolla R., Barluzzi R., Romani L., Mosci P., and Bistoni F. (1991) Anti-Candida resistance in the mouse brain and effect of intracerebral administration of interleukin 1.J. Gen. Microbiol. 137, 1799–1804.
Merrill J. E., Koyanagi Y., Zack J., Thomas L., Martin F., and Chen I.S.Y. (1992) Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1.J. Virol. 66, 2217–2225.
Minami M., Kuraishi Y., Yamaguchi T., Nakai S., Hirai Y., and Satoh M. (1990) Convulsants induce interleukin-1β messenger RNA in rat brain.Biochem. Biophys. Res. Commun. 171, 832–837.
Ohga S., Aoki T., Okada K., Akeda H., Fujioka K., Ohshima A., Mori T., Minamishima I., and Ueda K. (1994) Cerebrospinal fluid concentrations of interleukin-1β, tumour necrosis factor-α, and interferon gamma in bacterial meningitis.Arch. Dis. Childhood 70, 123–125.
Oldenburg H. S. A., Pruitt J. H., Lazarus D. D., Rogy M. A., Chizzonite R., Lowry S. F., and Moldawer L. L. (1995) Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response.Cytokine 7, 510–516.
Opara E. I., Laviano A., Meguid M. M., and Yang Z. J. (1995) Correlation between food intake and CSF IL-1 alpha in anorectic tumor bearing rats.Neuro-Report 6, 750–752.
Perrella O., Carrieri P. B., Guarnaccia D., and Soscia M. (1992) Cerebrospinal fluid cytokines in AIDS dementia complex.J. Neurol. 239, 387,388.
Plata-Salamán C. R. (1991) Immunoregulators in the nervous system.Neurosci. Biobehav. Rev. 15, 185–215.
Plata-Salamán C. R. (1992) Interferons and central regulation of feeding.Am. J. Physiol. 263, R1222-R1227.
Plata-Salamán C. R. (1994) Meal patterns in response to the intracerebroventricular administration of interleukin-1β in rats.Physiol. Behav. 55, 727–733.
Plata-Salamán C. R. and ffrench-Mullen J. M. H. (1994) Interleukin-1β inhibits calcium channel currents in isolated hippocampal CA1 neurons through protein kinase C.Eur. J. Pharmacol. Mol. Pharmacol. Sect. 266, 1–10.
Plata-Salamán C. R., Sonti G., and Borkoski J. P. (1995a) Modulation of feeding by β2-microglobulin, a marker of immune activation.Am. J. Physiol. 268, R1513-R1519.
Plata-Salamán C. R., Sonti G., Wilson C. D., and ffrench-Mullen J. M. H. (1995b) Chronic intracerebroventricular (ICV) microinfusion of cytokines: i) differential effects on feeding; ii) profile of Gα-protein subunit subclasses in the ventromedial hypothalamic nucleus (VMN).Soc. Neurosci. Abst. USA 21, 966.
Reinisch N., Wolkersdorfer M., Kähler C., Ye K., Dinarello C. A., and Wiedermann C. J. (1994) Interleukin-1 receptor type I mRNA in mouse brain as affected by peripheral administration of bacterial lipopolysaccharide.Neurosci. Lett. 166, 165–167.
Schöbitz B., Holsboer F., and Ron de Kloet E. (1994) Cytokines in the healthy and diseased brain.NIPS 9, 138–142.
Sims J. E., Gayle M. A., Slack J. L., Alderson M. R., Bird T. A., Giri J. G., Colotta F., Re F., Mantovani A., Shanebeck K., Grabstein K. H., and Dower S. D. (1993) Interleukin-1 signalling occurs exclusively via the type 1 receptor.Proc. Natl. Acad. Sci. USA 90, 6155–6159.
Sonti G., Ilyin S. E., and Plata-Salamán C. R. (1996) Anorexia induced by cytokine interactions at pathophysiological concentrations.Am. J. Physiol. 270, R139-R1402.
Symons J. A., Bundick R. V., Suckling A. J., and Rumsby M. G. (1987) Cerebrospinal fluid interleukin 1-like activity during chronic relapsing experimental allergic encephalomyelitis.Clin. Exp. Immunol. 68, 648–654.
Takao T., Tracey D. E., Mitchell W. M., and De Souza E. B. (1990) Interleukin-1 receptors in mouse brain: characterization and neuronal localization.Endocrinology 127, 3070–3078.
Takii T., Akahoshi T., Kato K., Hayashi H., Marunouchi T., and Onozaki K. (1992) Interleukin-1 up-regulates transcription of its own receptor in human fibroblast cell line TIG-1: role of endogenous PGE2 and cAMP.Eur. J. Immunol. 22, 1221–1227.
Taupin V., Toulmond S., Serrano A., Benavides J., and Zavala F. (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre-traumatic and post-traumatic treatment with Ro 05-4864, a peripheral-type (p-site) benzodiazepine ligand.J. Neuroimmunol. 42, 177–185.
Thomas W. E. (1992) Brain macrophages: evaluation of microglia and their functions.Brain Res. Rev. 17, 61–74.
Tomozawa Y., Inoue T., and Satoh M. (1995) Expression of type I interleukin-1 receptor mRNA and its regulation in cultured astrocytes.Neurosci. Lett. 195, 57–60.
Van Deuren M., van der Ven-Jongekrijg J., Bartelink A. K. M., van Dalen R., Sauerwein R. W., and van der Meer J. W. M. (1995) Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections.J. Infect. Dis. 172, 433–439.
Vogels M. T. E., Mensink E. J. B. M., Ye K., Boerman O. C., Verschueren C. M. M., Dinarello C. A., and van der Meer J. W. M. (1994) Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection.J. Immunol. 153, 5772–5780.
Wießner C., Gehrmann J., Lindholm D., Töpper R., Kreutzberg G. W., and Hossmann K. A. (1993) Expression of transforming growth factor-β1 and interleukin-1β mRNA in rat brain following transient forebrain ischemia.Acta Neuropathol. 86, 439–446.
Williams G. T., McClanahan T. K., and Morimoto R. I. (1989) E1a transactivation of the humanHSP70 promoter is mediated through the basal transcriptional complex.Mol. Cell. Biol. 9, 2574–2587.
Yabuuchi K., Minami M., Katsumata S., and Satoh M. (1993) In situ hybridization study of interleukin-1β mRNA induced by kainic acid in the brain.Mol. Brain Res. 20, 153–161.
Yabuuchi K., Minami M., Katsumata S., and Satoh M. (1994a) Localization of type I interleukin-1 receptor mRNA in the rat brain.Mol. Brain Res. 27, 27–36.
Yabuuchi K., Minami M., Katsumata S., Yamazaki A., and Satoh M. (1994b) An in situ hybridization study of interleukin-1β mRNA induced by transient forebrain ischemia in the rat brain.Mol. Brain Res. 26, 135–142.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ilyin, S.E., Sonti, G., Gayle, D. et al. Regulation of brain interleukin-1β (IL-1β) system mRNAs in response to pathophysiological concentrations of IL-1β in the cerebrospinal fluid. J Mol Neurosci 7, 169–181 (1996). https://doi.org/10.1007/BF02736838
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02736838